These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33170578)

  • 21. Differentiated Care Preferences of Stable Patients on Antiretroviral Therapy in Zambia: A Discrete Choice Experiment.
    Eshun-Wilson I; Mukumbwa-Mwenechanya M; Kim HY; Zannolini A; Mwamba CP; Dowdy D; Kalunkumya E; Lumpa M; Beres LK; Roy M; Sharma A; Topp SM; Glidden DV; Padian N; Ehrenkranz P; Sikazwe I; Holmes CB; Bolton-Moore C; Geng EH
    J Acquir Immune Defic Syndr; 2019 Aug; 81(5):540-546. PubMed ID: 31021988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia.
    Koole O; Tsui S; Wabwire-Mangen F; Kwesigabo G; Menten J; Mulenga M; Auld A; Agolory S; Mukadi YD; Colebunders R; Bangsberg DR; van Praag E; Torpey K; Williams S; Kaplan J; Zee A; Denison J
    Trop Med Int Health; 2014 Dec; 19(12):1397-410. PubMed ID: 25227621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Similar costs and outcomes for differentiated service delivery models for HIV treatment in Uganda.
    Guthrie T; Muheki C; Rosen S; Kanoowe S; Lagony S; Greener R; Miot J; Balidawa H; Kiggundu J; Calnan J; Dejene S; Xulu T; Sigwebela N; Long LC
    BMC Health Serv Res; 2022 Nov; 22(1):1315. PubMed ID: 36329450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of implementing universal and rapid HIV treatment on initiation of antiretroviral therapy and retention in care in Zambia: a natural experiment using regression discontinuity.
    Mody A; Sikazwe I; Namwase AS; Wa Mwanza M; Savory T; Mwila A; Mulenga L; Herce ME; Mweebo K; Somwe P; Eshun-Wilson I; Sikombe K; Beres LK; Pry J; Holmes CB; Bolton-Moore C; Geng EH
    Lancet HIV; 2021 Dec; 8(12):e755-e765. PubMed ID: 34656208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained Retention, Viral Load Suppression and their Determinants Among Clients on HAART Enrolled Under Differentiated Service Delivery Models in Eastern Uganda.
    Brian J; Waiswa S; Balinaine J; Lomuria R; Nabutanyi GG; Ongala E; Opus B; Olwedo MA; Iramiot JS; Oboth P; Nekaka R
    Res Sq; 2023 Oct; ():. PubMed ID: 37886502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV testing and treatment coverage achieved after 4 years across 14 urban and peri-urban communities in Zambia and South Africa: An analysis of findings from the HPTN 071 (PopART) trial.
    Floyd S; Shanaube K; Yang B; Schaap A; Griffith S; Phiri M; Macleod D; Sloot R; Sabapathy K; Bond V; Bock P; Ayles H; Fidler S; Hayes R;
    PLoS Med; 2020 Apr; 17(4):e1003067. PubMed ID: 32240156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding implementation barriers in the national scale-up of differentiated ART delivery in Uganda.
    Zakumumpa H; Rujumba J; Kwiringira J; Katureebe C; Spicer N
    BMC Health Serv Res; 2020 Mar; 20(1):222. PubMed ID: 32183796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic evaluation of a cluster randomized, non-inferiority trial of differentiated service delivery models of HIV treatment in Zimbabwe.
    Benade M; Nichols BE; Fatti G; Kuchukhidze S; Takarinda K; Mabhena-Ngorima N; Grimwood A; Rosen S
    PLOS Glob Public Health; 2023; 3(3):e0000493. PubMed ID: 36962960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of a Multistate Model to Evaluate Visit Burden and Patient Stability to Improve Sustainability of Human Immunodeficiency Virus Treatment in Zambia.
    Roy M; Holmes C; Sikazwe I; Savory T; Mwanza MW; Bolton Moore C; Mulenga K; Czaicki N; Glidden DV; Padian N; Geng E
    Clin Infect Dis; 2018 Sep; 67(8):1269-1277. PubMed ID: 29635466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Annual cost of antiretroviral therapy among three service delivery models in Uganda.
    Vu L; Waliggo S; Zieman B; Jani N; Buzaalirwa L; Okoboi S; Okal J; Borse NN; Kalibala S
    J Int AIDS Soc; 2016; 19(5 Suppl 4):20840. PubMed ID: 27443270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Community ART Groups on retention-in-care among patients on ART in Tete Province, Mozambique: a cohort study.
    Decroo T; Telfer B; Dores CD; White RA; Santos ND; Mkwamba A; Dezembro S; Joffrisse M; Ellman T; Metcalf C
    BMJ Open; 2017 Aug; 7(8):e016800. PubMed ID: 28801427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Sequential Multiple Assignment Randomized Trial of scalable interventions for ART delivery in South Africa: the SMART ART study.
    van Heerden A; Szpiro A; Ntinga X; Celum C; van Rooyen H; Essack Z; Barnabas R
    Trials; 2023 Jan; 24(1):32. PubMed ID: 36647092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preferences of people living with HIV for differentiated care models in Kenya: A discrete choice experiment.
    Dommaraju S; Hagey J; Odeny TA; Okaka S; Kadima J; Bukusi EA; Cohen CR; Kwena Z; Eshun-Wilson I; Geng E
    PLoS One; 2021; 16(8):e0255650. PubMed ID: 34432795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa.
    Fox MP; Pascoe S; Huber AN; Murphy J; Phokojoe M; Gorgens M; Rosen S; Wilson D; Pillay Y; Fraser-Hurt N
    PLoS Med; 2019 Jul; 16(7):e1002874. PubMed ID: 31335865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiated Service Delivery Models for HIV Treatment in Malawi, South Africa, and Zambia: A Landscape Analysis.
    Huber A; Pascoe S; Nichols B; Long L; Kuchukhidze S; Phiri B; Tchereni T; Rosen S
    Glob Health Sci Pract; 2021 Jun; 9(2):296-307. PubMed ID: 34234023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can differentiated care models solve the crisis in HIV treatment financing? Analysis of prospects for 38 countries in sub-Saharan Africa.
    Barker C; Dutta A; Klein K
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21648. PubMed ID: 28770597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redefining and revisiting cost estimates of routine ART care in Zambia: an analysis of ten clinics.
    Tucker A; Tembo T; Tampi RP; Mutale J; Mukumba-Mwenechanya M; Sharma A; Dowdy DW; Moore CB; Geng E; Holmes CB; Sikazwe I; Sohn H
    J Int AIDS Soc; 2020 Feb; 23(2):e25431. PubMed ID: 32064766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PEBRA trial - effect of a peer-educator coordinated preference-based ART service delivery model on viral suppression among adolescents and young adults living with HIV: protocol of a cluster-randomized clinical trial in rural Lesotho.
    Lejone TI; Kopo M; Bachmann N; Brown JA; Glass TR; Muhairwe J; Matsela T; Scherrer R; Chere L; Namane T; Labhardt ND; Amstutz A
    BMC Public Health; 2020 Mar; 20(1):425. PubMed ID: 32228531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality improvement intervention to increase adherence to ART prescription policy at HIV treatment clinics in Lusaka, Zambia: A cluster randomized trial.
    McCarthy EA; Subramaniam HL; Prust ML; Prescott MR; Mpasela F; Mwango A; Namonje L; Moyo C; Chibuye B; van den Broek JW; Hehman L; Moberley S
    PLoS One; 2017; 12(4):e0175534. PubMed ID: 28419106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of different community models of antiretroviral therapy delivery with the standard of care among stable HIV+ patients: rationale and design of a non-inferiority cluster randomized trial, nested in the HPTN 071 (PopART) study.
    Limbada M; Bwalya C; Macleod D; Floyd S; Schaap A; Situmbeko V; Hayes R; Fidler S; Ayles H;
    Trials; 2021 Jan; 22(1):52. PubMed ID: 33430928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.